COS 2014 has been designed with assistance from professionals and practitioners engaged in managing clinical outsourcing contracts. The symposium is focused on assessing both common pitfall and paramount practices associated with optimal results in managing clinically outsourced contracts.
The key stakeholders include Pharma, Biopharma and Small to Medium Biotechs; Contract Research Organisation (CROs), Site Management Organisations (SMOs), Academics and hospitals – as well as analytical service companies, consultancies and niche players. PharmaDialogue suggests the sheer diversity of stakeholders is pushing the industry to closer integration. COS 2014 is focused on addressing cost, technology and regulation and their impact on the nature of clinical outsourced contracts. In that integration is seen as a fundamental opportunity to both retain and reduce the loss of information. Resulting in higher levels of transparency in a given relationship involved with any clinical outsourced contract.
The Clinical Outsourcing Strategies Symposium is a platform for all stakeholders to engage in benchmarking, learning and using the platform as a key point for finding solutions. The case studies, master class workshop, presentations and networking. Sessions are all focused on providing you with a unique opportunity; to learn, network and conduct one-to-one meetings to address your business needs for the next 12 to 18 months.
CLINICAL OUTSOURCING STRATEGIES SYMPOSIUM COS 2014
WHY SHOULD I ATTEND? THE AMSTERDAM COS NETWORK:
Clinical Outsourcing is not a new concept in world of Pharma but it experienced exceptional growth during the mid to late 90s, this development has been continuous to date. Given the extent of our research: PharmaDialogue suggests an unprecedented increase of investment among the top 100 global Pharma and bio-Pharma companies. This is now a homogenous strategy among all major Pharma/Biopharma companies to engage and overcome dwindling pipelines.
The Clinical Outsourcing Strategies Symposium has been designed as a platform on address key challenges associated with managing clinically outsourced contracts. Specifically assessing the changing nature of regulatory requirements, the role of technology, cost v time and a further assessment of best practice in managing contract transparency among others.
COS 2014 – Clinical Outsourcing Symposium is a platform where by the top 100 Pharma and Biopharma companies in EU; can engage their counterpart from prominent CRO organisations.
KEY BENEFITS COS 2015: CLINICAL OUTSOURCING STRATEGIES
• Negotiating partnerships rather than contracts
• Learn how to manage contract expectations
• Key platform for buyers and sellers
• Understand the impact of location
• Updates on emerging and BRIC nations
• Harmonising and streamlining your processes
• Process integration in regards
• Assess the best solutions for information retention
+44 (0) 207 096 1152